Evidence map›Paper›PMID 42898598›Full record

ArticleFrontiers in plant science2026

Light spectrum effects on huperzine A and B accumulation in axenic gametophyte cultures of

Wojciech J Szypuła, Marta Maciejczyk, Beata Wileńska

Abstract read
In one paragraph

Article in Frontiers in plant science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wojciech J SzypułaDepartment of Pharmaceutical Biology, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland.
Marta MaciejczykDepartment of Pharmaceutical Biology, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland.
Beata WileńskaDepartment of Pharmaceutical Biology, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Huperzine A (HupA) and huperzine B (HupB) are high-value Lycopodiaceae alkaloids with potent, reversible acetylcholinesterase (AChE) inhibitory activity and NMDA receptor antagonism. Their supply is limited by impractical field cultivation and conservation constraints on wild harvesting. Here, we evaluated axenic gametophyte cultures of Methods: Cultures were maintained for 24 weeks under three light treatments (WHITE-L, BLUE-L and RED-BLUE-L) or darkness. HupA and HupB were quantified by HPLC-DAD, while LC-MS/IT-TOF and MS/MS-supported profiling were used for target-alkaloid confirmation and characterization of the multi-component extract composition. Extracts standardized to HupA equivalents were evaluated for AChE inhibition. Results: LED spectral control shaped HupA/HupB accumulation patterns. BLUE-L (≈450 nm) was associated with the strongest increase in HupA content, reaching 4.83 ± 0.21 mg·g Discussion: The weak-to-moderate relationship between HupA content and AChE inhibition suggests that optimization of

Indexed as

AChE inhibitionaxenic gametophytesHuperzia selagohuperzine Ahuperzine Bin vitro culturelight spectrumspecialized metabolism

Identifiers

PMID42898598
PMCPMC13677926

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.